Jun 01, 2021 / 05:00PM GMT
Malgorzata Maria Kaczor Andrew - William Blair & Company L.L.C., Research Division - Partner
Hi. Good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst here at William Blair & Company who covers Dexcom.
Before we begin, I am required to inform you that I personally own shares of Dexcom. And beyond that, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.
Now as you guys are all familiar based on the past year, given the virtual nature of the conference, we've moved to a fireside chat style discussion. There is a way to submit some questions online. So definitely do so. And I'll, of course, ask them as best as I can.
But with that, we're very pleased to have Jereme Sylvain, CFO of Dexcom and Brice Bobzien, VP of Finance here with us today. Jereme and Brice, I hope you guys are doing well, and thanks for joining us.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Absolutely. Thanks for having us today. Looking forward to it.
Dexcom Inc at William Blair Growth Stock Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
